Orange Book product · Generic (ANDA)
NOREPINEPHRINE BITARTRATE
NOREPINEPHRINE BITARTRATE
At a glance
Sep 30, 2004
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 30, 2004
22 yr ago
Today
Pharmaceutical detail
Active ingredient
NOREPINEPHRINE BITARTRATE
Strength
EQ 1MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 040522
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NOREPINEPHRINE BITARTRATE
- 2026NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDEBrand (NDA)
NDA 214313 · BAXTER HLTHCARE CORP
- 2022NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDEBrand (NDA)
NDA 214628 · LONG GROVE PHARMS
- 2022NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDEBrand (NDA)
NDA 215700 · INFORLIFE
- —LEVOPHEDBrand (NDA)
NDA 007513 · HOSPIRA
- 2026NOREPINEPHRINE BITARTRATEGeneric (ANDA)
ANDA 216272 · NEPHRON
- 2026NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEGeneric (ANDA)
ANDA 220483 · SAGENT
- 2025NOREPINEPHRINE BITARTRATEGeneric (ANDA)
ANDA 218595 · MSN
- 2025NOREPINEPHRINE BITARTRATEGeneric (ANDA)
ANDA 219924 · ANTHEA PHARMA
- 2025NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEGeneric (ANDA)
ANDA 219692 · SAGENT
- 2025NOREPINEPHRINE BITARTRATEGeneric (ANDA)
ANDA 219443 · BIOCON PHARMA
- 2025NOREPINEPHRINE BITARTRATEGeneric (ANDA)
ANDA 219163 · ASPIRO
- 2024NOREPINEPHRINE BITARTRATEGeneric (ANDA)
ANDA 218758 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
